{"id":10025,"date":"2006-06-29T00:00:00","date_gmt":"2006-06-28T22:00:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/etichette-doc-dei-principi-attivi\/"},"modified":"2006-06-29T00:00:00","modified_gmt":"2006-06-28T22:00:00","slug":"etichette-doc-dei-principi-attivi","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/etichette-doc-dei-principi-attivi\/","title":{"rendered":"Doc labels of active ingredients."},"content":{"rendered":"
On the track there is a collection of signatures among EU parliamentarians to ask for the introduction of traceability of every active pharmaceutical ingredient and to discourage the relabelling and repackaging of non-EU products. \u00abIt will take three months and 367 adhesions to consider the "written declaration" containing these requests as approved by the plenary and therefore binding for the Commission and the Council\u00bb guarantees Amelia Sartori (Ppe), member of the European Parliament's Safety, Environment, Public Health and Food Commission, who spoke in recent days at the Bulk@Italy international event promoted by Aschimfarma (association of sector producers belonging to Federchimica).
A very important promise for the sector, which in 2005 recorded a total turnover of 3 billion euro despite discounting a difficult situation: "In 2006 we estimate a growth in volume of 1% but we would not yet be able to compete with India and China" explains the president of Aschimfarma, Gian Mario Boccalini.
In fact, about 80% of the active ingredients consumed in Europe comes from Asian countries with lower costs than 25-40% and without the obligation to show a Good manufacturing practice certificate that guarantees the quality and safety of the molecule.
An unjustly penalizing situation, concludes Boccalini, for a sector that still represents a flagship of Italian chemicals \u00abboasting an 89% of production destined for export (40% to the United States, 34% in Europe, and a 17% in Japan), with 8,000 employees, and a turnover per employee of 370,000 euros\u00bb.
<\/span>S.TOD<\/span>. (the sun \u2013 24 hours 06\/25\/06)
<\/span><\/div>","protected":false},"excerpt":{"rendered":"

In pista c’è una raccolta di firme tra i parlamentari Ue per chiedere l’introduzione della tracciabilità di ogni principio attivo farmaceutico e disincentivare la rietichettatura  e il riconfezionamento dei prodotti extracomunitari. «Serviranno tre mesi di tempo e 367 adesioni per considerare la “dichiarazione scritta” recante queste richieste come approvata dall’aula e dunque vincolante per la …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-10025","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=10025"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10025\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=10025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=10025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=10025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}